Nano-X Imaging (NNOX) vs. Its Rivals Head-To-Head Survey

Nano-X Imaging (NASDAQ:NNOX – Get Free Report) is one of 510 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will compare Nano-X Imaging to related businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Nano-X Imaging and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging 1 2 2 0 2.20
Nano-X Imaging Competitors 4330 10559 18358 840 2.46

Nano-X Imaging currently has a consensus price target of $4.33, suggesting a potential upside of 1,784.06%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 28.77%. Given Nano-X Imaging’s higher possible upside, research analysts plainly believe Nano-X Imaging is more favorable than its competitors.

Profitability

This table compares Nano-X Imaging and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nano-X Imaging -926.05% -116.93% -100.67%
Nano-X Imaging Competitors -191.42% -197.86% -21.83%

Earnings & Valuation

This table compares Nano-X Imaging and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Nano-X Imaging $15.63 million -$75.02 million -0.11
Nano-X Imaging Competitors $1.90 billion $136.32 million 5.94

Nano-X Imaging’s competitors have higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Nano-X Imaging has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Nano-X Imaging’s competitors have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.

Insider and Institutional Ownership

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 40.3% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Nano-X Imaging competitors beat Nano-X Imaging on 11 of the 13 factors compared.

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. is an Israeli medical technology company developing digital X-ray imaging systems and related services. Its Nanox.ARC system is designed to produce medical images using the company’s digital X-ray technology, with the goal of expanding access to diagnostic imaging. The company’s broader offering includes Nanox.CLOUD, a cloud-based platform intended to connect imaging systems with image-management and diagnostic services, and Nanox.AI, which develops artificial-intelligence tools for analyzing medical images.

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.